Global Cell Expansion Market - Forecast 2026-2032 | Market to Reach USD 56.86 Billion as Automation, AI, and Cell and Gene Therapy Drive 15.80% CAGR

Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Cell Expansion Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

This market research report examines the global cell expansion market, projected to grow from USD 23.18 billion in 2026 to USD 56.86 billion by 2032 at a CAGR of 15.80%. It evaluates the technologies, manufacturing requirements, regional dynamics, and strategic priorities shaping cell expansion across biopharmaceutical production, regenerative medicine, cell and gene therapy, vaccine development, immuno-oncology, and translational research.

Market Growth and Demand Drivers

Demand is rising for scalable cell culture systems, serum-free and xeno-free media, single-use bioreactors, closed-system automation, and high-quality reagents that improve cell growth, viability, potency, reproducibility, and contamination control. Expanding regulatory activity and thousands of active cell therapy-related clinical studies reinforce the need for reliable expansion technologies.

As developers transition from laboratory workflows to clinical and commercial manufacturing, purchasing decisions increasingly emphasize:

The analysis supports strategic planning by clarifying where technology adoption, clinical demand, and manufacturing investment are creating commercially attractive opportunities.

Transformative Technology Shifts

The market is moving from open, manual, research-grade processes toward closed, automated, digitally monitored, and GMP-aligned manufacturing ecosystems. Autologous therapies require strong process control to address patient variability and short vein-to-vein timelines, while allogeneic therapies need larger, consistent batches produced on scalable platforms.

Suppliers are differentiating through integrated portfolios spanning media, growth factors, cultureware, bioreactors, sensors, analytics, cell separation, and cryopreservation. Skilled labor shortages, capacity constraints, cold-chain complexity, and quality-control demands are also accelerating adoption of modular manufacturing, single-use assemblies, automated processing, and digital batch records.

Artificial Intelligence Applications

Artificial intelligence and machine learning are improving experimental design, process optimization, quality prediction, and manufacturing decisions. Models can analyze cell counts, metabolite profiles, imaging, flow cytometry, sensor data, environmental monitoring, and electronic batch records.

Near-term applications include predictive process control, anomaly detection, media optimization, donor variability assessment, morphology tracking, and release-testing support. Digital twins can simulate scale-up scenarios before costly GMP resources are committed. Adoption nevertheless depends on data integrity, model explainability, cybersecurity, validation, audit-ready documentation, and regulatory alignment.

Regional and Economic Group Insights

ASEAN is emerging as a bioprocessing and clinical research corridor, while the GCC is linking advanced therapeutics to healthcare diversification. BRICS markets offer scale and localization potential, and G7 countries retain advantages in funding, regulation, intellectual property, and commercialization. These comparisons can inform market-entry priorities and partnership selection while helping organizations anticipate regional risks.

Strategic Priorities for Industry Leaders

Competitive benchmarking across these priorities provides decision-makers with a practical basis for investment allocation, risk mitigation, and sustainable differentiation.

Key Takeaways from This Report

Key Attributes

Key Topics Covered

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Expansion Market, by Product Type

7.1. Introduction

7.2. Cell Culture Media

7.2.1. Serum Based Media

7.2.2. Serum Free Media

7.3. Reagents

7.3.1. Buffers

7.3.2. Antibiotics

7.4. Bioreactors

7.4.1. Stirred Tank Bioreactors

7.4.2. Wave Bioreactors

7.4.3. Hollow Fiber Bioreactors

7.5. Cell Counters

7.6. Culture Vessels

8. Cell Expansion Market, by Technology

8.1. Introduction

8.2. 2D Cell Culture

8.3. 3D Cell Culture

8.3.1. Spheroid

8.3.2. Organoid

8.4. Scaffold based Culture

8.4.1. Hydrogel

8.4.2. Polymer

8.5. Suspension Culture

8.6. Perfusion Systems

9. Cell Expansion Market, by Cell Type

9.1. Introduction

9.2. Mammalian Cells

9.2.1. CHO Cells

9.2.2. HEK Cells

9.3. Stem Cells

9.4. Immune Cells

9.4.1. T Cells

9.4.2. NK Cells

9.4.3. Dendritic Cells

9.5. Microbial Cells

9.5.1. Bacteria

9.5.2. Yeast

9.6. Primary Cells

9.6.1. Hepatocytes

9.6.2. Fibroblasts

9.6.3. Endothelial

10. Cell Expansion Market, by Culture System

10.1. Introduction

10.2. Open

10.3. Closed

10.4. Automated

11. Cell Expansion Market, by Application

11.1. Introduction

11.2. Biopharmaceutical Production

11.2.1. Monoclonal Antibody Production

11.2.2. Recombinant Protein Production

11.3. Cell & Gene Therapy

11.4. Regenerative Medicine

11.4.1. Tissue Engineering

11.4.2. Organ Regeneration Research

11.5. Research & Development

11.6. Toxicology Testing

12. Cell Expansion Market, by End User

12.1. Introduction

12.2. Academic Research Institutes

12.3. Biotechnology Companies

12.4. Contract Manufacturing Organizations

12.5. Pharmaceutical Companies

13. Cell Expansion Market, by Region

13.1. Introduction

13.2. Asia-Pacific

13.3. North America

13.4. Latin America

13.5. Europe

13.6. Middle East

13.7. Africa

14. Cell Expansion Market, by Group

14.1. Introduction

14.2. ASEAN

14.3. GCC

14.4. European Union

14.5. BRICS

14.6. G7

14.7. NATO

15. Cell Expansion Market, by Country

15.1. Introduction

15.2. United States

15.3. Canada

15.4. Mexico

15.5. Brazil

15.6. United Kingdom

15.7. Germany

15.8. France

15.9. Russia

15.10. Italy

15.11. Spain

15.12. China

15.13. India

15.14. Japan

15.15. Australia

15.16. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025

16.2. Market Concentration Analysis, 2025

16.2.1. Concentration Ratio (CR)

16.2.2. Herfindahl Hirschman Index (HHI)

16.3. Recent Developments & Impact Analysis, 2025

16.4. Product Portfolio Analysis, 2025

16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Agilent Technologies Inc

17.2. Allogene Therapeutics Inc

17.3. Becton Dickinson and Company

17.4. Bio-Techne Corporation

17.5. Cellectis SA

17.6. CellGenix GmbH

17.7. Corning Incorporated

17.8. Cytiva Uppsala AB

17.9. Danaher Corporation

17.10. Eppendorf SE

17.11. FUJIFILM Irvine Scientific Inc

17.12. GE HealthCare Technologies Inc

17.13. Getinge AB

17.14. HiMedia Laboratories Pvt Ltd

17.15. Kite Pharma Inc

17.16. Lonza Group AG

17.17. Merck KGaA

17.18. Miltenyi Biotec GmbH

17.19. PBS Biotech Inc

17.20. Promab Biotechnologies Inc

17.21. PromoCell GmbH

17.22. Repligen Corporation

17.23. Sartorius AG

17.24. STEMCELL Technologies Inc

17.25. Takara Bio Inc

17.26. Takara Bio USA Holdings Inc

17.27. Terumo Corporation

17.28. Thermo Fisher Scientific Inc

17.29. WuXi AppTec Co Ltd

18. Key Experts

List of Figures [23]

List of Tables [378]

For more information about this report visit https://www.researchandmarkets.com/r/js5hwk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.